Production (Stage)
Kronos Bio, Inc.
KRON
$0.8702
-$0.0018-0.21%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.86M | 2.27M | 2.37M | 2.69M | 2.52M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.86M | 2.27M | 2.37M | 2.69M | 2.52M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 1.86M | 2.27M | 2.37M | 2.69M | 2.52M |
| SG&A Expenses | 6.12M | 5.64M | 6.55M | 7.10M | 8.39M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.24M | 13.33M | 18.09M | 20.13M | 21.73M |
| Operating Income | -6.37M | -11.06M | -15.72M | -17.45M | -19.21M |
| Income Before Tax | -8.36M | -25.81M | -14.11M | -16.20M | -29.96M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -8.36M | -25.81M | -14.11M | -16.20M | -29.96M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.36M | -25.81M | -14.11M | -16.20M | -29.96M |
| EBIT | -6.37M | -11.06M | -15.72M | -17.45M | -19.21M |
| EBITDA | -6.15M | -10.65M | -15.30M | -17.03M | -18.73M |
| EPS Basic | -0.14 | -0.43 | -0.23 | -0.27 | -0.50 |
| Normalized Basic EPS | -0.05 | -0.10 | -0.15 | -0.16 | -0.18 |
| EPS Diluted | -0.14 | -0.43 | -0.23 | -0.27 | -0.50 |
| Normalized Diluted EPS | -0.05 | -0.10 | -0.15 | -0.16 | -0.18 |
| Average Basic Shares Outstanding | 60.81M | 60.34M | 60.31M | 60.10M | 59.52M |
| Average Diluted Shares Outstanding | 60.81M | 60.34M | 60.31M | 60.10M | 59.52M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |